LATITUDE Programming System
FDA premarket approval P910077/S169 · decided 2019-07-08
Approval details
- PMA number
- P910077
- Supplement
- S169
- Supplement type
- Real-Time Process
- Supplement reason
- Change Design/Components/Specifications/Material
- Trade name
- LATITUDE Programming System
- Generic name
- Implantable cardioverter defibrillator (non-CRT)
- Applicant
- Boston Scientific
- Date received
- 2019-02-27
- Decision date
- 2019-07-08
- Days to decision
- 131 days
- Decision code
- APPR
- Product code
- LWS
- Advisory committee
- Cardiovascular
- Expedited review
- No
- Location
- St Paul, MN
- Statement
- Approval for changes to the printed circuit board assembly in the Model 3300 LATITUDE Programming System.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.